Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Taurine in First-Episode Psychosis
NCT00420823Phase 3Completed
- Sponsor
- Melbourne Health
- Start
- Jan 2007
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of taurine in psychotic disorder, sponsored by Melbourne Health. Started Jan 2007; status: completed.
02
Drugs
taurine
03
Conditions
psychotic disorder
Beyond the preview
Go deeper on NCT00420823.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00420823.